Journals / Ulusal Romatoloji Dergisi / 2021 / Cilt: 13 - Sayı: 1

The main differences between connective tissue diseases-associated interstitial lung disease and idiopathic pulmonary fibrosis

Bağ dokusu hastalıkları ile ilişkili interstisyel akciğer hastalığı ile idiyopatik pulmoner fibroz arasındaki temel farklar

Pages
22–28
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

However, rheumatoid arthritis may be in the UIP pattern and Sjögren’s syndrome in the LIP pattern.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Connective tissue diseases (CTD) can often cause respiratory system involvement.
📊
Key Findings & Data:Interstitial lung disease (ILD) is an example of respiratory system involvement, which is the most frequent cause of mortality and morbidity, which challenges patients and their physicians in routine practice.
💡
Conclusion & Impact:However, rheumatoid arthritis may be in the UIP pattern and Sjögren’s syndrome in the LIP pattern.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Connective tissue diseases (CTD) can often cause respiratory system involvement. Interstitial lung disease (ILD) is an example of respiratory system involvement, which is the most frequent cause of mortality and morbidity, which challenges patients and their physicians in routine practice. Idiopathic pulmonary fibrosis (IPF) is another common cause of ILD. Similarities between CTD-ILD and IPF in terms of pathogenic, clinical and radiological findings complicate the distinction of the two diseases. However, the treatment of CTD-ILD and IPF is very different. Therefore, it is very important to distinguish both. ILD is grouped histopathologically and radiologically as usual interstitial pneumonia (UIP), non-specific interstitial pneumonia (NSIP), lymphocytic interstitial pneumonia (LIP) and organized pneumonia. Patients with CTD-ILD in the NSIP pattern have a better response to immunosuppressive therapy than patients with the UIP pattern. The effectiveness of antifibrotic therapy is more prominent in patients with the UIP pattern. While IPF is in the UIP pattern, CTD-ILD is often in the NSIP pattern. However, rheumatoid arthritis may be in the UIP pattern and Sjögren’s syndrome in the LIP pattern.

Özet

Bağ dokusu hastalıkları (BDH) sıklıkla solunum sistemi tutulumlarına neden olabilmektedir. Rutin pratikte hasta ve hekimini en çok zorlayan, en sık mortalite ve morbidite nedeni olan solunum sistemi tutulum örneği interstisyel akciğer hastalığıdır (İAH). İdiyopatik pulmoner fibroz (İPF) sık karşılaşılan İAH nedenlerinden bir diğeridir. BDH-İAH ile İPF arasındaki patojenik, klinik ve radyolojik bulgular bakımından önemli oranlarda benzerlikler iki hastalığın ayrımını güçleştirmektedir. Ancak, BDH-İAH ile İPF’nin tedavisi çok farklıdır. Bu nedenle, her ikisinin ayrımını yapmak oldukça önemlidir. İAH, histopatolojik ve radyolojik olarak, usual interstisyel pnömoni (UİP), non-spesifik interstisyel pnömoni (NSİP), lenfositik interstisyel pnömoni (LİP) ve organize pnömoni olarak gruplandırılır. NSİP paterninde BDH-İAH olan hastalarda immünosüpresif tedaviye yanıt UİP paterni olan hastalardan daha iyidir. UİP paterni olan hastalarda antifibrotik tedavinin etkinliği daha belirgindir. İPF UİP paterninde iken, BDH-İAH sıklıkla NSİP paternindedir. Ancak, romatoid artrit UİP, Sjögren sendromu ise LİP paterninde olabilir

🔖

Cite This Article

Karataş, A., Koca, S. S., Gür, M., Öz, B., Sağır, R. P. (2022). The main differences between connective tissue diseases-associated interstitial lung disease and idiopathic pulmonary fibrosis. Ulusal Romatoloji Dergisi, Cilt: 13 - Sayı: 1, 22–28. https://ajindex.com/articles/643873

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Rosas IO, Dellaripa PF, Lederer DJ, Khanna D, Young LR, Martinez FJ. Interstitial lung disease: NHLBI workshop on the primary prevention of chronic lung diseases. Ann Am Thorac Soc 2014;11(Suppl 3):S169-77
  2. Travis WD, Costabel U, Hansell DM, et al. An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2013;188:733-48
  3. Mira-Avendano I, Abril A, Burger CD, et al. Interstitial lung disease and other pulmonary manifestations in connective tissue diseases. Mayo Clin Proc 2019;94:309-25
  4. Fischer A, Strek ME, Cottin V, et al. Proceedings of the American College of Rheumatology/Association of Physicians of Great Britain and Ireland connective tissue disease-associated interstitial lung disease summit: a multidisciplinary approach to address challenges and opportunities. Arthritis Rheumatol 2019;71:182-95
  5. Perelas A, Silver RM, Arrossi AV, Highland KB. Systemic sclerosis-associated interstitial lung disease. Lancet Respir Med 2020;8:304-20
  6. Denton CP, Wells AU, Coghlan JG. Major lung complications of systemic sclerosis. Nat Rev Rheumatol 2018;14:511-27
  7. Perelas A, Arrossi AV, Highland KB. Pulmonary manifestations of systemic sclerosis and mixed connective tissue disease. Clin Chest Med 2019;40:501-18
  8. Farquhar H, Vassallo R, Edwards AL, Matteson EL. Pulmonary complications of rheumatoid arthritis. Semin Respir Crit Care Med 2019;40:194-207 9. Flament T, Bigot A, Chaigne B, Henique H, Diot E, Marchand- Adam S. Pulmonary manifestations of Sjögren’s syndrome. Eur Respir Rev 2016;25:110-23
  9. Lopez Velazquez M, Highland KB. Pulmonary manifestations of systemic lupus erythematosus and Sjögren’s syndrome. Curr Opin Rheumatol 2018;30:449-64
  10. Hervier B, Uzunhan Y. Inflammatory myopathy-related interstitial lung disease: from pathophysiology to treatment. Front Med (Lausanne) 2020;6:326
  11. Lederer DJ, Martinez FJ. Idiopathic pulmonary fibrosis. N Engl J Med 2018;378:1811-23
  12. Raghu G, Collard HR, Egan JJ, et al. An official ATS/ERS/JRS/ ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011;183:788-824
  13. Fischer A, Antoniou KM, Brown KK, et al. An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features. Eur Respir J 2015;46:976-87. 1